Company intelligence / Profile preview

GreenLight Biosciences

Lexington, Massachusetts, United Statesgreenlightbiosciences.com ↗
Ownership
Private
Employees
~138
Development stage
Commercial
01

Overview

GreenLight’s lead product “Calantha” demonstrated efficacy as an RNAi bioinsecticide against Colorado potato beetle in field trials. Its bioherbicide candidate targeting horseweed has shown consistent activity in greenhouse/field studies. Other pipeline candidates include solutions for varroa mite control and fungal pathogens like powdery mildew. No human clinical results reported.

Therapeutic areas
OtherInfectious Diseases
Modalities
RNA therapySmall interfering RNA (siRNA)Messenger RNA (mRNA)-based drugsDouble-stranded RNA (dsRNA)Biologic
Industry
Agriculture & AgTech
02

Drug pipeline

3 assets

Calantha

Commercial
Indications
Colorado potato beetle control

2 more assets in the full pipeline.

Request access →
03

Partnerships

Collaborations with academic institutions on platform developmentIndustry partnerships implied through technology outlicensing/offering platform access to partners

Beyond the preview

Go deeper on GreenLight Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GreenLight Biosciences.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call